BioCentury
ARTICLE | Clinical News

CK-2017357 regulatory update

March 15, 2010 7:00 AM UTC

FDA granted Orphan Drug designation to Cytokinetics' CK-2017357 to treat amyotrophic lateral sclerosis (ALS). The company plans to start a Phase II trial for the skeletal muscle troponin activator thi...